bioAffinity Technologies, Inc. (NASDAQ: BIAF) reported Q1 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $2.62 million.

For earnings history and earnings-related data on bioAffinity Technologies, Inc. (BIAF) click here.